Drug Database
AN

anti-D immunoglobulin

✓ Approved

Kedrion · 多克隆抗体 · 多克隆抗体

什么是 anti-D immunoglobulin?

anti-D immunoglobulin 是一种多克隆抗体,由Kedrion研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intramuscular (IM) Injection。

药物档案

公司Kedrion
药物类别多克隆抗体, 细胞治疗, 抗体
给药途径Injectable (Others), Intramuscular (IM) Injection
状态Approved

治疗适应症

anti-D immunoglobulin 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Congenital, familial and genetic disordersRhesus haemolytic disease of newborn✓ Approved

相关研究文献

PubMedBMC plant biology2026-11-19

Transcriptome and metabolite conjoint analysis reveals that exogenous methyl jasmonate regulates terpenoid synthesis in Dryopteris fragrans.

Zhang Jiaqi J, Dai Weicong W, Zhang Dongrui D, Zhao Jingran J et al.

Methyl jasmonate (MeJA) is a plant chemical elicitor that has been used to artificially induce chemical defense responses and trigger induced resistance against a broad range of arthropod herbivores. Exogenous spraying of MeJA on plant leaves can promote the synthesis of a variety of plant secondary metabolites and induce the production of defense products. Dryopteris fragrans (L.) Schott is a Dryopteris plant of Dryopteridaceae. Terpenoids in D. fragrans have many functions, such as anti-tumor, antipruritic, antibacterial, anti allergy and so on. Exogenous application of 800 µmol/L MeJA to D. fragrans leaves for 12 h elicited notable physiological and metabolic changes. Physiologically, MDA content decreased, whereas proline, soluble protein, and the activities of antioxidant enzymes (SOD, POD, and CAT) increased. Metabolically, GC-MS analysis revealed a significant accumulation of terpenoids. Transcriptomic profiling identified 27,312 DEGs. KEGG enrichment analysis showed that 14 and 10 DEGs were mapped to the MVA and MEP pathways, respectively, while 3 and 10 DEGs were associated with monoterpenoid and diterpenoid biosynthesis, respectively. These results indicate that the MVA pathway exhibited a more pronounced transcriptional response to MeJA treatment. this study represents the first pioneering report on the global transcriptomic profiling of D. fragrans in response to MeJA treatment. Collectively, these findings lay the groundwork for future investigations into the development, stress resilience, and secondary metabolic pathways of this species.

PMID 43052730
阅读全文 →
PubMedMycotoxin research2026-11-19

Biological mycotoxin d​etoxification in dried fruits: food safety challenges and barriers to industrial translation.

Qala Kaoutar K, Abdelmoumen Hanaa H

Despite decades of research demonstrating the detoxification potential of microorganisms and enzymes, biological mycotoxin detoxification has achieved only limited industrial implementation, particularly in dried fruits. This persistent gap between laboratory efficacy and practical application remains one of the major unresolved challenges in the field. Rather than providing another descriptive overview of detoxification mechanisms or biological agents, this critical narrative review examines the scientific, technological, regulatory, and commercial barriers limiting industrial translation. A structured literature search was conducted in Scopus, Web of Science, PubMed/MEDLINE, ScienceDirect, and Google Scholar, supplemented by screening the reference lists of relevant publications. Studies were selected according to their relevance to biological mycotoxin reduction, the mechanisms demonstrated, the food matrices investigated, and their implications for safety and industrial applicability, with priority given to publications from 2020 onward. The review highlights a substantial gap between reported laboratory efficacy and demonstrated applicability to dried fruits, as much of the available evidence derives from culture media, simplified food models, or other matrices, including cereals and feed. The low water activity and high sugar content of dried fruits further complicate the transfer of findings from other food systems. Additional barriers include reversible toxin adsorption, insufficient toxicological characterization of transformation products, methodological heterogeneity, limited process robustness, scale-up challenges, regulatory uncertainty, and economic feasibility. Advancing industrial implementation requires matrix-specific validation in naturally contaminated dried fruits under realistic processing and storage conditions, standardized assessment of detoxification mechanisms, and evidence that toxin reduction translates into a demonstrable decrease in toxicological risk. This review identifies research priorities to support the development of safe, scalable, and economically viable biological interventions for dried-fruit processing.

PMID 43052622
阅读全文 →
PubMedClinical pediatrics2026-11-19

Patterns and Factors Associated With Coronary Artery Involvement in Kawasaki Disease: Experience From Southern Tunisia.

Elleuch Amal A, Elleuch Imen I, Ben Halima Asma A, Gargouri Rania R et al.

Kawasaki disease (KD) is a paediatric vasculitis associated with coronary complications. We aimed to describe clinical and echocardiographic characteristics and factors associated with coronary involvement. This retrospective, single-centre study included 70 children over 18 years (2007-2024). Univariate analyses assessed clinical and laboratory associations. The mean age was 55.4 ± 32.8 months; 61.7% were younger than 5 years. Coronary involvement occurred in 32/70 (45.7%), including dilation in 25 (35.7%), wall thickening in 7 (10.0%) and aneurysms in 3 (4.3%). Lesions regressed in 27/32 (84.4%). Significant associations included cheilitis, rash, cervical lymphadenopathy, cough, rhinorrhoea, leucocytosis, lymphocytosis, lower mean corpuscular volume, higher mean corpuscular haemoglobin concentration, thrombocytosis and elevated alanine aminotransferase. These unadjusted associations do not establish independent predictors. Early diagnosis, intravenous immunoglobulin and aspirin remain essential. Systematic echocardiographic assessment, structured follow-up and larger multicentre studies are needed to improve coronary risk stratification and long-term outcomes in children with KD.

PMID 43052696
阅读全文 →
PubMedSmall (Weinheim an der Bergstrasse, Germany)2026-11-19

eQt Protein Nanocage-Delivered IL-21 mRNA Systemically Reprograms Host Immune Cells Toward Stemness and Maturation to Achieve Anti-Tumor Immunity.

Shen Ruitong R, Zhang Jinsong J, Zhang Huan H, Liu Jinsong J et al.

Effective cancer immunotherapy requires reprogramming host immunity toward stem-like states. However, clinical use of IL-21 is limited by short half-life and toxicity. Here, we develop a bio-inspired protein nanocage platform (eQt) that encapsulates IL-21 mRNA via high-affinity λN-boxB interactions during bacterial biosynthesis, enabling one-step manufacturing and pH-responsive endosomal release. eQt-IL-21 drives dendritic cell maturation, characterized by marked upregulation of CD80 and CD86, and transcriptome-wide enrichment of MHC-I antigen processing and presentation pathways (H2-K1, H2-D1, B2m, Tap2), establishing a highly stimulatory environment for T cell priming. Transcriptomic profiling of draining lymph nodes reveals that eQt-IL-21 preferentially diverts CD8+ T-cell differentiation away from terminal exhaustion toward a TCF-1+/CCR7+ stem-like progenitor identity, with concordant upregulation of Tcf7, Sell (encoding CD62L), and LEF-1, sustaining a self-renewing memory reservoir and long-lived central memory T cells (Tcm). In preclinical E.G7-OVA models, this immunological reprogramming translates into potent prophylactic efficacy and durable therapeutic remission of established tumors, without detectable systemic toxicity. This work establishes IL-21 mRNA-mediated immune-cell reprogramming as a mechanistic cornerstone of durable anti-tumor immunity, and positions the eQt nanocage as a versatile, scalable platform for precision cancer immunotherapy.

PMID 43053577
阅读全文 →
PubMedBMC neurology2026-11-19

Glymphatic system dysfunction in anti-NMDAR encephalitis: a comparative DTI-ALPS study with healthy controls and epilepsy patients.

Xu Zijian Z, Wang Dongmei D, Zhou Fang F, Zhong Junyuan J et al.

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is characterized by pathogenic autoantibody-mediated synaptic dysfunction, yet the mechanisms facilitating antibody access to the brain parenchyma remain incompletely understood. The glymphatic system, which supports cerebrospinal fluid-interstitial fluid exchange along perivascular spaces, has been implicated in immune surveillance and waste clearance; however, its involvement in anti-NMDAR encephalitis has not been fully investigated in vivo. Glymphatic system-related function was assessed using diffusion tensor imaging along the perivascular space (DTI-ALPS) in 15 patients with anti-NMDAR encephalitis, 17 patients with epilepsy, and 18 healthy controls. Group differences in ALPS-index values were analyzed with adjustment for age and sex. Associations between ALPS-indexes, clinical severity, and regional brain volumes were further examined. ALPS-index values were significantly reduced in both anti-NMDAR encephalitis and epilepsy compared with healthy controls. Across all groups, ALPS-indexes demonstrated strong bilateral correlations, with consistently lower values in the right hemisphere. In anti-NMDAR encephalitis, lower ALPS-index values were associated with longer hospitalization and higher modified Rankin Scale scores, whereas no associations were observed with cerebrospinal fluid anti-NMDAR antibody titers. In epilepsy, ALPS-indexes showed a distinct pattern of clinical and structural correlations, including associations with regional brain volumes that were absent in the NMDAR group. Receiver operating characteristic analysis indicated moderate-to-good discriminative performance of ALPS-indexes for both disease groups. DTI-ALPS reveals altered perivascular water diffusivity in anti-NMDAR encephalitis, which correlates with clinical severity independently of antibody titers. These findings suggest glymphatic-related dysfunction in anti-NMDAR encephalitis, and indicate that the ALPS-index captures disease-relevant pathophysiological processes beyond antibody burden, with potential utility as a noninvasive imaging marker for clinical assessment and prognosis in immune-mediated encephalitis.

PMID 43052821
阅读全文 →
PubMedHaematologica2026-11-19

Comment on: "Effect of intravenous immunoglobulin on infections in multiple myeloma patients receiving daratumumab".

Rago Angela A, Zomparelli Marco M, Di Toritto Tommaso Caravita TC

PMID 43053702
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多anti-D immunoglobulin